Expert Speaker Faculty

REGISTER
BRAND-NEW AGENDA
PARTNER

Andy Judd

Medicinal Chemist

Abbvie

Anna Engstrom

Senior Principal Scientist & Toxicologist Safety Assessment

Genentech

Carole Harbison

Associate Scientific Fellow, Pathology

Takeda Pharmaceutical

Funda Meric-Bernstam

Chair of Department of Investigational Cancer Therapeutics, Division of Cancer Medicine

The University of Texas MD Anderson Cancer Center

Grace Lytle

Executive Director, Ocular Medical

AbbVie

Jennifer Brown

Senior Director of Toxicology

MacroGenics

John Kwon

Associate Director

AstraZeneca

Julia Kristensson

Associate Director

Bicycle Therapeutics

Kristin Decker

Associate Director Pharmacology & Toxicology

Heidelberg Pharma

Megan Terral

Director of Scientific Operations

AxoSim

Neel Pasricha

Assistant Professor of Ophthalmology

University of Califorina, San Francisco

Nicolas Quesnot

Senior Scientist, Preclinical Safety

Debiopharm

Paolo Tarantino

Clinical Research Fellow

Dana-Farber Cancer Institute

Raymond Evers

Senior Director, Global Translational ADME, Translational PK/PD & Investigative Toxicology

Johnson & Johnson

Robert Lutz

Chief Scientific Officer

Iksuda Therapeutics

Ronnie Yeager

Project Director, Emerging Therapeutic Platforms Beacon

Abbvie

Sonia Jain

Research Associate Radiation Oncology

Mayo Clinic

Steve Everett

Chief Executive Officer

MaveriX Oncology

Yu-Tzu Tai

Associate Director

Oxford BioTherapeutics

Zenta Tsuchihashi

Senior Director, Clinical Safety & Pharmacovigilance

Daiichi Sankyo

VIEW THE BRAND NEW AGENDA HERE